000 | 01835 a2200517 4500 | ||
---|---|---|---|
005 | 20250516232410.0 | ||
264 | 0 | _c20161017 | |
008 | 201610s 0 0 eng d | ||
022 | _a1873-2402 | ||
024 | 7 |
_a10.1016/j.biopsych.2014.07.019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFeyder, Michael | |
245 | 0 | 0 |
_aA Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB Expression. _h[electronic resource] |
260 |
_bBiological psychiatry _cMar 2016 |
||
300 |
_a362-371 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntiparkinson Agents _xadverse effects |
650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xmetabolism |
650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xdrug effects |
650 | 0 | 4 |
_aHistones _xmetabolism |
650 | 0 | 4 |
_aLevodopa _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aNeostriatum _xdrug effects |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aOxidopamine _xadministration & dosage |
650 | 0 | 4 |
_aParkinson Disease _xcomplications |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xmetabolism |
650 | 0 | 4 |
_aRibosomal Protein S6 Kinases, 90-kDa _xmetabolism |
700 | 1 | _aSödersten, Erik | |
700 | 1 | _aSantini, Emanuela | |
700 | 1 | _aVialou, Vincent | |
700 | 1 | _aLaPlant, Quincey | |
700 | 1 | _aWatts, Emily L | |
700 | 1 | _aSpigolon, Giada | |
700 | 1 | _aHansen, Klaus | |
700 | 1 | _aCaboche, Jocelyne | |
700 | 1 | _aNestler, Eric J | |
700 | 1 | _aFisone, Gilberto | |
773 | 0 |
_tBiological psychiatry _gvol. 79 _gno. 5 _gp. 362-371 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopsych.2014.07.019 _zAvailable from publisher's website |
999 |
_c24163837 _d24163837 |